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Cover: The unusual shape of a mouse pancreatic islet immunostained for insulin (green), the neural cell adhesion molecule NCAM (red), and
DAPI. If you could ask a question to pancreatic islets, what would that be? Surprising as it can be, it appears as if this time it was the islet of
Langerhans itself asking a question, “Do you really think you know enough about me?!” Image courtesy of Vincenzo Cirulli, Joseph Nadler, and
Antonio J. Jimenez-Caliani, Diabetes and Obesity Center of Excellence, Department of Medicine, Institute for Stem Cell and Regenerative
Medicine, University of Washington, Seattle, Washington.
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